Date: September 25, 2026

Litigation Update

Northern TK Venture Pte Ltd (NTK), the promoter shareholder of Fortis Healthcare Limited, has filed a petition for appeal with the Tokyo High Court on September 24, 2026 against the judgment issued by the Tokyo District Court dated September 10, 2026. NTK concluded that the judgment warrants appellate review by a higher court and has exercised its right of appeal to present its arguments before the Tokyo High Court.

Background and Context

This disclosure is made under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, referencing SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company has made previous announcements on this matter dated November 14, 2023, December 26, 2023, February 23, 2024, May 14, 2024, August 21, 2024, November 7, 2024, February 6, 2025, May 20, 2025, February 19, 2026, April 29, 2026 and September 11, 2026.

IHH Healthcare's Position

IHH Healthcare Berhad (IHH), through its media statement, maintains that it has suffered losses arising from delays in obtaining mandatory tender offer approvals required for its acquisition of Fortis Healthcare. These delays occurred in the context of a dispute between Daiichi Sankyo and certain judgment debtors, to which IHH was not a party.

IHH emphasizes that its acquisition of Fortis in 2018 was undertaken through a transparent, widely publicized and fully regulated process that obtained all necessary corporate, shareholder and regulatory approvals, including those required under the Competition Commission of India (CCI) and SEBI takeover regulations.

Strategic Commitment to India

IHH reaffirms its commitment to India as a key strategic market, stating plans to increase its stake in Fortis to 51% over the next three to five years. The company plans to further integrate Fortis and Gleneagles platforms and expand capacity to approximately 10,000 beds by 2031 to meet India's growing healthcare needs.

Future Communications

Fortis Healthcare Limited will inform stakeholders of any material developments on this matter as they occur.